Alexion Pharmaceuticals, Inc. · 10 hours ago
Clinical Information Science Intern
Alexion Pharmaceuticals, Inc. is looking for Sophomore and Junior students for a 12-week internship role. The position involves data sourcing and preparation, creating reproducible workflows, and collaborating with stakeholders to gather requirements and validate use cases.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Data sourcing and preparation: Identify, ingest, and clean structured and unstructured datasets; document data lineage, assumptions, and quality checks
Reproducible workflows: Use Git, notebooks, and code review to ensure version control, documentation, and repeatable analyses
Stakeholder collaboration: Gather requirements, validate use cases, and iterate on findings with internal and external partners
Qualification
Required
Sophomore and Junior students majoring in Computer Science, Information Sciences, Engineering, Data science, or a related field
Candidates must have an expected graduation date after August 2026
Programming proficiency in at least one programming language (for e.g. Python, R, SQL): Data manipulation, analysis, and basic modeling using clean, well-documented code
ETL understanding: Extract, transform, and load data from multiple sources into analytics-ready structures and storage
Basic level of Database knowledge: Work with relational databases and write efficient SQL for data retrieval, joins, and performance-aware queries
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week
Preferred
Data visualization experience preferable (Tableau, Power BI, similar): Build intuitive dashboards and charts tailored to stakeholder needs
Machine Learning and AI Familiarity preferred
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase